MedTrace Logo

Effect of Remifentanil on Pruritus and Paresthesia of Fospropofol Disodium Anesthesia

NCT07092384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2025-12-29

No results posted yet for this study

Summary

Explore the effect of remifentanil on pruritus and paresthesia induced by fospropofol disodium in adults

Conditions

  • Remifentanil
  • Adverse Effects

Interventions

DRUG

Remifentanil

Observe the incidence of pruritus and paresthesia after different doses of remifentanil and fospropofol disodium

DRUG

Sufentanil

Observe the incidence of pruritus and paresthesia after sufentanil and fospropofol disodium

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • aihua Du, Dr. · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-30
Primary Completion
2025-11-30
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07092384 on ClinicalTrials.gov